Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02572791 · ClinicalTrials.gov registry record · Phase 4
Staph Household Intervention for Eradication (SHINE)
A Phase 4 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 835
- Enrollment target
NCT02572791 is a Phase 4 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 835 participants.
The verdict
NCT02572791, a Phase 4 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 835 participants
- Enrollment target
Study Summary
The investigators propose a pragmatic comparative effectiveness trial evaluating several decolonization strategies in patients with Staphylococcus aureus infection, their household contacts, and household environmental surfaces. The central hypothesis of this proposal is that an integrated approach of periodic personal and household environmental hygiene will reduce S. aureus transmission in households and subsequently decrease the incidence of skin and soft tissue infections (SSTI).
Interventions
- DRUG Mupirocin
- DRUG Chlorhexidine
- BEHAVIORAL Household cleaning
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 835 participants |
| Start Date | 2015-10 |
| Est. Completion | 2024-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02572791
The ClinicalTrials.gov registry entry for NCT02572791 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 835 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Mupirocin is the first listed.
NCT02572791 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02572791 about?
NCT02572791 is a clinical study titled "Staph Household Intervention for Eradication (SHINE)". The investigators propose a pragmatic comparative effectiveness trial evaluating several decolonization strategies in patients with Staphylococcus aureus infection, their household contacts, and household environmental surfaces. The central hypothesis of this proposal is that an integrated approach ...
What is the current status of trial NCT02572791?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 835 participants. The study started on 2015-10. Estimated completion is 2024-12.
What interventions are being tested in trial NCT02572791?
The interventions under investigation include: Mupirocin (DRUG), Chlorhexidine (DRUG), Household cleaning (BEHAVIORAL).
Who is sponsoring clinical trial NCT02572791?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.